scholarly journals Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab with Maintenance Bevacizumab as a First-line Treatment for Advanced Non-squamous Non-small Cell Lung Cancer in Elderly Patients

2018 ◽  
Vol 38 (6) ◽  
pp. 3779-3784 ◽  
Author(s):  
HIROAKI TAKEOKA ◽  
KAZUHIKO YAMADA ◽  
YOSHIKO NAITO ◽  
NORIKAZU MATSUO ◽  
HIDENOBU ISHII ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Treatment

Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): A phase II trial

Lung Cancer ◽  
2013 ◽  
Vol 80 (2) ◽  
pp. 185-190 ◽  
Author(s):  
Radj Gervais ◽  
Gilles Robinet ◽  
Christelle Clément-Duchêne ◽  
Fabrice Denis ◽  
Claude El Kouri ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document